Spatial Genomics & Transcriptomics Market

Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Academic Institute, Research Institutes, CROs) - Global Forecast to 2025

Report Code: BT 7790 Nov, 2020, by marketsandmarkets.com

[ 201 Pages Report] The global spatial genomics & transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development. Increasing investment in biopharmaceutical R&D. On the other hand, lack of awareness about these techniques in the emerging countries and the high cost of instruments are some factors limiting the market growth.

Global Spatial Genomics & Transcriptomics Market Trend

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the global Spatial Genomics & Transcriptomics market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has since moved from being a regional crisis to a global pandemic. With the World Health Organization (WHO) officially declared the outbreak of the virus a pandemic, a mix of established pharmaceutical companies, as well as small startups, has stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. In June 2020, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, introduced new solutions to study the immune response in COVID-19 disease research. The company launched the nCounter Host Response Gene Expression Panel and the COVID-19 Panel Plus spike-in to provide a comprehensive analysis of the viral infection and immune response.

The sudden outbreak of COVID-19 has had a positive as well as a negative impact on the pharmaceutical as well as the life science industry globally. Certain market segments have been more severely affected due to the low demand for instruments, consumables, and reagents, as well as due to supply chain disruptions and trade restrictions.

The impact of the pandemic and slowing global research activities have also had a negative impact on the operations and financial performance of many of the players in the market. Due to the shutting down of academic & research institutes, there has been a decline in the sales of consumables & reagents used for spatial genomics & transcriptomics analysis. According to the Q2 2020 results published by Nanostring Technologies Inc., the company witnessed a massive decline of 34.0% in its Consumables segment compared to Q2 2019. According to the Q2 2020 results published by 10X Genomics Inc., the company observed a decline of 23.0% compared to Q2 2019.

Although severely affected by the pandemic, the global spatial genomics and transcriptomics market is expected to grow at a higher rate in the next two years. The increased use of spatial genomics & transcriptomics analysis for biomarker identification, coupled with the adoption of these techniques by market players for drug discovery & development, is likely to boost the market growth in the coming years.

Spatial genomics & transcriptomics Market Dynamics

Driver: Increasing adoption of spatial genomics & transcriptomics in drug discovery & development

In recent years, spatial genomics and transcriptomics have shifted from strictly research applications to drug discovery & development applications. Genomics and transcriptomics are major tools for accelerating drug discovery & development processes. With the rapidly increasing global burden of chronic diseases such as cancer and diabetes, there is a need for advanced technologies for drug discovery and development.

Various market players operating in the spatial genomics and transcriptomics market are constantly focusing on developing and introducing novel instruments and techniques for drug discovery & development. This is one of the major factors driving the market growth.

Opportunity: Increasing use of spatial omics for biomarker identification

Biomarker identification, along with its clinical applications, has simplified drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs. Besides, biomarkers for diseases like cancer, CVD, and neurological diseases play an integral role in enabling a better understanding of the disease pathway and progression.The discovery of new biomarkers in the diagnosis of various diseases, especially cancer diagnosis, has brought about revolutionary changes in medicine. Furthermore, continuous developments in sequencing technologies have increased the efficiency of biomarkers in disease detection and their utilization in disease diagnoses.

The increasing demand for biomarkers is expected to boost the transcriptomics technologies market. The huge addressable market for biomarkers, along with the growing applications of transcriptomics in biomarker discovery, is expected to provide significant growth opportunities for the overall market for the next few years. According to GLOBOCAN, 18,078,957 new cancer cases were registered in 2018; this number is expected to reach 29.5 million by 2040. The rising prevalence of cancer has compelled researchers to focus on identifying markers that can distinguish between indolent and aggressive cancers. Currently, there is no way to predict which genes will reposition in cancer. However, based on spatial positioning, which is regulated in a normal cell, it may become easier to predict regions that will be diagnostically potential. Key market players offer various products for the biomarker identification of various disease conditions. For instance, 10X Genomics provides Visium Spatial Gene Expression, which is a next-generation molecular technology for classifying tissue based on total mRNA. 

Challenges: Dearth of skilled professionals

Spatial genomics and transcriptomics is a relatively new area of omics research. The global development of spatial transcriptomics research has been concentrated in the US and other developed countries in Europe. Moreover, even in these countries, spatial transcriptomics research is relatively small compared to other areas of omics research. Due to this, only limited research expertise is available in this field.

Transcriptome analysis comprises the use of sophisticated methods to study biological entities within a laboratory setup. It involves labor-intensive techniques to perform experiments and requires skilled professionals such as researchers and technicians to set up and run tests and experiments, make observations, obtain results, and analyze data. Lack of knowledge regarding the underlying scientific principles and the right choice of technique may result in several direct and indirect expenses and, thereby, increase the workload and time pressure on researchers and service providers. Thus, there is a need for highly skilled personnel for method development, validation, operation, and troubleshooting activities. In January 2017, the European Commission issued a warning about a projected 1 million shortfall in Europe’s clinical workforce by 2020. A similar shortfall of professionals is expected in the Asia Pacific and Latin American regions. Countries like Japan, India, Brazil, Mexico, and Argentina are also expected to face a shortage of trained professionals for technical positions in research. Thus, the lack of clarity around outcomes of transcriptomic research, coupled with the high cost of equipment, has led to the lower adoption of transcriptomic technologies, thereby limiting the spread of technical knowledge related to transcriptomics research. 

By techniques, the spatial transcriptomics techniquessegment accounted for the largest share of the spatial genomics & transcriptomics market in 2019.

Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global spatial genomics and transcriptomics market. This segment is projected to reach USD 268.3 million by 2025 from USD 115.5 million in 2020, at the highest CAGR of 18.4%. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.

By product, the consumables segment accounted for the largest share of the spatial genomics & transcriptomics market in 2019.

Based on product, the spatial genomics and transcriptomics market is categorized into instruments, consumables, and software. In 2019, consumables accounted for the largest share in the global spatial genomics and transcriptomics market. The growing applications of spatial genomics and transcriptomics in various fields such as drug discovery & development and biomarker identification and the growing use of consumables are the key factors driving the market growth.

By application, the pharmaceutical manufacturing applications segment accounted for the largest share of the spatial genomics & transcriptomics market in 2019.

Based on application, the spatial genomics and transcriptomics market is segmented into translational research and drug discovery & development. The translational research application segment accounted for the largest share of the market in 2019. The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

By end user, the academic & research institutes segment accounted for the largest share of the spatial genomics & transcriptomics market in 2019.

Based on end users, the spatial genomics and transcriptomics market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2019, the academic & research institutes segment accounted for the largest share of the spatial genomics and transcriptomics market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.

North America accounted for the largest share of the spatial genomics & transcriptomics market in 2019.

In 2019, North America held the largest share of 55.6% of the global market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics and transcriptomics market in this region. 

Key Market Players

10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the spatial genomics and transcriptomics market.

Scope of the report 

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD Million)

Segments Covered

Technique, Product, Application, End User and Region

Geographies Covered

North America, Europe, APAC, Latin America and Middle East & Africa

Companies Covered

The major market players include as NanoString Technologies, 10X Genomics, Illumina, Bio-Techne, Fluidigm Corporation, ReadCoor, and S2 Genomics
(Total 19 companies)

The study categorizes the spatial genomics & transcriptomics market into the following segments and subsegments:

Technique

  • Spatial Transcriptomics
    • Immunohistochemistry (IHC)
    • In Situ Hybridization
    • Sequencing Technologies
    • Microscopy-based RNA Imaging
    • Other Spatial Transcriptomics Techniques
  • Spatial Genomics Analysis
    • Fluorescence In Situ Hybridization (FISH)
    • Sequencing Techniques
    • Others Spatial Genomics Analysis Techniques
  • Product
    • Instruments
    • Consumables
    • Softwares

By Application

  • Translational Research
  • Drug Discovery & Development

By End User

  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa 

Recent Developments

  • In August 2020, NanoString Technologies released Cancer Transcriptome Atlas, a new product based on the company’s GeoMx Digital Spatial Profiler (DSP) platform that is optimized for readout on Illumina’s next-generation sequencing (NGS) technology.
  • In February 2020, S2 Genomics launched Singulator 100 System that automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a wide range of single-cell biology and genomic analyses.
  • In April 2017, NuGEN Technologies, Inc. launched the Trio RNA-Seq kits and Universal Plus mRNA-Seq, which assist in RNA-Seq analyses from monotonous samples isolated from the sources. Trio RNA-Seq offers an extremely delicate complete transcriptomics solution that is preferably matched for applications with low profusion transcripts, such as biomarker assessment or the detection of viral transcripts in liquid biopsy samples.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION  (Page No. - 21)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 25)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
           2.1.3 DATA TRIANGULATION
    2.2 MARKET ESTIMATION METHODOLOGY
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    2.3 MARKET GROWTH RATE PROJECTIONS
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 31)

4 PREMIUM INSIGHTS (Page No. - 35)
    4.1 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW
    4.2 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT & COUNTRY (2019)
    4.3 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE,  BY END USER (2019)
    4.4 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    4.5 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. - 39)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery & development
                    5.2.1.2 Introduction of novel products
                    5.2.1.3 Increasing R&D investments and public-private funding
           5.2.2 RESTRAINTS
                    5.2.2.1 High capital investments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing use of spatial omics for biomarker identification
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled professionals
    5.3 PRICING ANALYSIS
    5.4 IMPACT OF COVID-19 ON THE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET

6 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY TECHNIQUE (Page No. - 46)
    6.1 INTRODUCTION
    6.2 SPATIAL TRANSCRIPTOMICS
           6.2.1 IMMUNOHISTOCHEMISTRY (IHC)
                    6.2.1.1 Emergence of multiplex immunohistochemistry/ immunofluorescence (mIHC/IF) is likely to propel growth in this segment
           6.2.2 IN SITU HYBRIDIZATION
                    6.2.2.1 High adoption of MERFISH technique to drive the growth of this segment
           6.2.3 SEQUENCING TECHNOLOGIES
                    6.2.3.1 Microdissection-based sequencing
                               6.2.3.1.1 Increasing use of microdissection-based sequencing techniques is likely to contribute towards market growth
                    6.2.3.2 In situ sequencing technologies
                               6.2.3.2.1 Increased adoption of in situ sequencing technologies is likely to drive the growth of the sequencing technology segment
                    6.2.3.3 Other sequencing technologies
           6.2.4 MICROSCOPY-BASED RNA IMAGING
                    6.2.4.1 Increasing utilization of microscopy-based RNA imaging techniques for spatial analysis to drive segmental growth
           6.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
    6.3 SPATIAL GENOMICS ANALYSIS
           6.3.1 FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
                    6.3.1.1 Emerging potential of spatial genomics analysis as a cancer diagnostic tool is likely to propel segmental growth
           6.3.2 SEQUENCING TECHNIQUES
                    6.3.2.1 Growing adoption of massively-parallel sequencing to boost growth in this market segment
           6.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES

7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY PRODUCT (Page No. - 74)
    7.1 INTRODUCTION
    7.2 CONSUMABLES
           7.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE MARKET GROWTH
    7.3 INSTRUMENTS
           7.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE GROWTH IN THIS MARKET SEGMENT
    7.4 SOFTWARE
           7.4.1 INCREASING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS IS PROPELLING THE DEMAND FOR SOFTWARE


8 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY APPLICATION (Page No. - 82)
    8.1 INTRODUCTION
    8.2 TRANSLATIONAL RESEARCH
           8.2.1 INCREASED FUNDING FOR RESEARCH ACTIVITIES TO PROPEL THE GROWTH OF THIS APPLICATION SEGMENT
    8.3 DRUG DISCOVERY & DEVELOPMENT
           8.3.1 INCREASING USE OF SPATIAL GENOMICS AND TRANSCRIPTOMICS IN DRUG DISCOVERY & DEVELOPMENT APPLICATIONS TO DRIVE MARKET GROWTH

9 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY END USER (Page No. - 88)
    9.1 INTRODUCTION
    9.2 ACADEMIC & RESEARCH INSTITUTES
           9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USE OF SPATIAL GENOMICS AND TRANSCRIPTOMICS IN ACADEMIC & RESEARCH INSTITUTES
    9.3 CONTRACT RESEARCH ORGANIZATIONS
           9.3.1 INCREASING DEPENDENCE ON CONTRACT RESEARCH ORGANIZATIONS FOR R&D BY MARKET PLAYERS TO DRIVE MARKET GROWTH
    9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF SPATIAL GENOMICS & TRANSCRIPTOMICS SYSTEMS & SERVICES IN PHARMA & BIOTECH COMPANIES

10 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY REGION (Page No. - 95)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
           10.2.1 US
                    10.2.1.1 The US dominates the North American spatial genomics and transcriptomics market during the forecast period
           10.2.2 CANADA
                    10.2.2.1 Government initiatives are supporting the growth of the market in Canada
     10.3 EUROPE
           10.3.1 GERMANY
                    10.3.1.1 Increasing adoption of spatial genomics and transcriptomics  by biopharma & biotech companies in Germany to drive market growth
           10.3.2 UK
                    10.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies, including spatial genomics & transcriptomics
           10.3.3 FRANCE
                    10.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
           10.3.4 REST OF EUROPE (ROE)
     10.4 ASIA PACIFIC (APAC)
           10.4.1 CHINA
                    10.4.1.1 Increasing R&D spending by government and biopharma companies to support market growth
           10.4.2 JAPAN
                    10.4.2.1 Increased research funding in Japan has created growth opportunities for spatial genomics & transcriptomics research
           10.4.3 REST OF ASIA PACIFIC (ROAPAC)
     10.5 LATIN AMERICA (LATAM)
           10.5.1 BRAZIL
                    10.5.1.1 Increased adoption of spatial analysis for translational research in Brazil likely to propel the market
           10.5.2 MEXICO
                    10.5.2.1 Increasing investments in the biotechnology industry to drive market growth in Mexico
           10.5.3 REST OF LATIN AMERICA (ROLATAM)
     10.6 MIDDLE EAST & AFRICA (MEA)
           10.6.1 SOUTH AFRICA
                    10.6.1.1 Growing investments in research & development support market development
           10.6.2 REST OF MIDDLE EAST & AFRICA (ROMEA)

11 COMPETITIVE LANDSCAPE (Page No. - 146)
     11.1 OVERVIEW
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY MARKET PLAYERS
     11.3 MARKET SHARE ANALYSIS
     11.4 KEY MARKET DEVELOPMENTS
           11.4.1 KEY PRODUCT LAUNCHES
           11.4.2 KEY MERGERS & ACQUISITIONS
           11.4.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
           11.4.4 EXPANSIONS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 153)
     12.1 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX, 2019
           12.1.1 STARS
           12.1.2 EMERGING LEADERS
           12.1.3 PERVASIVE PLAYERS
           12.1.4 PARTICIPANTS
     12.2 COMPANY PROFILES
           12.2.1 NANOSTRING TECHNOLOGIES, INC.
                    12.2.1.1 Business overview
                    12.2.1.2 Products offered
                    12.2.1.3 Recent developments
                    12.2.1.4 SWOT analysis
                    12.2.1.5 MnM view
           12.2.2 10X GENOMICS, INC.
                    12.2.2.1 Business overview
                    12.2.2.2 Products offered
                    12.2.2.3 Recent developments
                    12.2.2.4 SWOT analysis
                    12.2.2.5 MnM view
           12.2.3 ILLUMINA INC.
                    12.2.3.1 Business overview
                    12.2.3.2 Products offered
                    12.2.3.3 Recent developments
                    12.2.3.4 SWOT analysis
                    12.2.3.5 MnM view
           12.2.4 BIO-RAD LABORATORIES, INC.
                    12.2.4.1 Business overview
                    12.2.4.2 Products offered
                    12.2.4.3 Recent developments
           12.2.5 BIO-TECHNE
                    12.2.5.1 Business overview
                    12.2.5.2 Products offered
                    12.2.5.3 Recent developments
           12.2.6 FLUIDIGM CORPORATION
                    12.2.6.1 Business overview
                    12.2.6.2 Products offered
                    12.2.6.3 Recent developments
           12.2.7 GENOMIC VISION
                    12.2.7.1 Business overview
                    12.2.7.2 Products offered
           12.2.8 SEVEN BRIDGES GENOMICS
                    12.2.8.1 Business overview
                    12.2.8.2 Products offered
                    12.2.8.3 Recent developments
           12.2.9 READCOOR, INC.
                    12.2.9.1 Business overview
                    12.2.9.2 Products offered
                    12.2.9.3 Recent developments
           12.2.10 S2 GENOMICS, INC.
                    12.2.10.1 Business overview
                    12.2.10.2 Products offered
                    12.2.10.3 Recent developments
           12.2.11 DOVETAIL GENOMICS
                    12.2.11.1 Business overview
                    12.2.11.2 Products offered
                    12.2.11.3 Recent developments
           12.2.12 AKOYA BIOSCIENCES, INC.
                    12.2.12.1 Business overview
                    12.2.12.2 Products offered
           12.2.13 VIZGEN CORP.
                    12.2.13.1 Business overview
                    12.2.13.2 Products offered
           12.2.14 BIOSPYDER, INC.
                    12.2.14.1 Business overview
                    12.2.14.2 Products offered
           12.2.15 OPTICAL BIOSYSTEMS, INC.
           12.2.15.1 Business overview
                    12.2.15.2 Products offered
           12.2.16 MILTENYI BIOTEC
                    12.2.16.1 Business overview
                    12.2.16.2 Products offered
                    12.2.16.3 Recent developments
           12.2.17 RARECYTE, INC.
                    12.2.17.1 Business overview
                    12.2.17.2 Products offered
                    12.2.17.3 Recent developments
           12.2.18 ULTIVUE, INC.
                    12.2.18.1 Business overview
                    12.2.18.2 Products offered
                    12.2.18.3 Recent developments
           12.2.19 CYTIVA
                    12.2.19.1 Business overview
                    12.2.19.2 Products offered

13 APPENDIX (Page No. - 194)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS
 
LIST OF TABLES (218 Tables) 
 
TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
TABLE 2 AVERAGE SELLING PRICE OF PRODUCTS USED IN GENOMICS & TRANSCRIPTOMICS,  BY REGION (2019)
TABLE 3 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 4 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 5 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY REGION,  2018-2025 (USD MILLION)
TABLE 6 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 7 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 8 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 9 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 11 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY,  BY REGION, 2018-2025 (USD MILLION)
TABLE 12 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 13 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 15 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 17 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION,  BY REGION, 2018-2025 (USD MILLION)
TABLE 18 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 19 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 21 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 23 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 24 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 25 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 26 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 27 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 28 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 30 SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY REGION, 2018-2025 (USD MILLION)
TABLE 31 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 32 EUROPE: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 33 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 34 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR MICRODISSECTION-BASED SEQUENCING, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 36 SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR IN SITU SEQUENCING TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 37 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR IN SITU SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 38 EUROPE: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR IN SITU SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 39 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET FOR IN SITU SEQUENCING TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 40 OTHER SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 41 NORTH AMERICA: OTHER SPATIAL TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 42 SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2018-2025 (USD MILLION)
TABLE 43 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 44 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 46 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 48 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY REGION,  2018-2025 (USD MILLION)
TABLE 49 NORTH AMERICA: OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 50 SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 51 SPATIAL GENOMICS ANALYSIS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 52 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 53 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 54 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 55 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 56 SPATIAL GENOMICS ANALYSIS MARKET FOR FLUORESCENCE IN SITU HYBRIDIZATION,  BY REGION, 2018-2025 (USD MILLION)
TABLE 57 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET FOR FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 58 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET FOR FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 59 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET FOR FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 60 SPATIAL GENOMICS ANALYSIS MARKET FOR SEQUENCING TECHNIQUES, BY REGION, 2018-2025 (USD MILLION)
TABLE 61 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET FOR SEQUENCING TECHNIQUES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 62 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET FOR SEQUENCING TECHNIQUES,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 63 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY REGION,  2018-2025 (USD MILLION)
TABLE 64 NORTH AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 65 EUROPE: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 67 LATIN AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 68 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 69 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 70 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 71 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 73 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 75 SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET,  BY REGION, 2018-2025 (USD MILLION)
TABLE 76 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 77 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 79 SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY REGION,  2018-2025 (USD MILLION)
TABLE 80 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 81 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 82 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 83 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 84 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2018-2025 (USD MILLION)
TABLE 85 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 86 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 88 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 90 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
TABLE 91 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 92 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 93 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 94 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 95 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-20250 (USD MILLION)
TABLE 96 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 97 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 98 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 99 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 100 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
TABLE 101 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 102 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 104 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
TABLE 105 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 106 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY REGION,  2018-2025 (USD MILLION)
TABLE 107 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 108 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 109 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 110 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 111 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 112 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 113 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 114 US: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 115 US: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 116 US: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 117 US: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 118 US: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 119 US: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 120 CANADA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 121 CANADA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 122 CANADA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 123 CANADA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 124 CANADA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 125 CANADA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 126 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
TABLE 127 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 128 EUROPE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 129 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 130 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 131 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 132 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 133 GERMANY: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 134 GERMANY: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 135 GERMANY: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 136 GERMANY: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 137 GERMANY: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 138 GERMANY: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 139 UK: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 140 UK: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 141 UK: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 142 UK: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 143 UK: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 144 UK: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 145 FRANCE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 146 FRANCE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 147 FRANCE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 148 FRANCE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 149 FRANCE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 150 FRANCE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 151 ROE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 152 ROE: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 153 ROE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 154 ROE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 155 ROE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 156 ROE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 157 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 158 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 159 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 160 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 161 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 162 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 163 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 164 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 165 CHINA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 166 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 167 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 168 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 169 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 170 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 171 JAPAN: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 172 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 173 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 174 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 175 ROAPAC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 176 ROAPAC: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 177 ROAPAC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 178 ROAPAC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 179 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 180 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 181 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 182 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 183 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 184 BRAZIL: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 185 BRAZIL: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 186 BRAZIL: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 187 BRAZIL: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 188 BRAZIL: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 189 BRAZIL: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 190 MEXICO: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 191 MEXICO: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
TABLE 192 MEXICO: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 193 MEXICO: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
TABLE 194 ROLATAM: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 195 ROLATAM: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 196 ROLATAM: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 197 ROLATAM: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 198 ROLATAM: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 199 ROLATAM: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 200 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 201 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,  BY END USER, 2018-2025 (USD MILLION)
TABLE 207 SOUTH AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
TABLE 208 SOUTH AFRICA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 209 SOUTH AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 210 SOUTH AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 211 SOUTH AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 212 SOUTH AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 213 ROMEA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
TABLE 214 ROMEA: SPATIAL TRANSCRIPTOMICS TECHNIQUES MARKET, BY TYPE,  2018-2025 (USD MILLION)
TABLE 215 ROMEA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 216 ROMEA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 217 ROMEA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
TABLE 218 ROMEA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2018-2025 (USD MILLION)
 
 
LIST OF FIGURES (29 Figures) 
 
FIGURE 1 BREAKDOWN OF PRIMARIES: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
FIGURE 2 DATA TRIANGULATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE-BASED ESTIMATION), 2019
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 2 (MNM REPOSITORY ANALYSIS-BASED ESTIMATION), 2019
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 6 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET (SUPPLY SIDE):  CAGR PROJECTIONS
FIGURE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 8 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION, 2019
FIGURE 9 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER,  2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
FIGURE 11 INCREASING ADOPTION OF SPATIAL GENOMICS & TRANSCRIPTOMICS ANALYSIS IN TRANSLATIONAL RESEARCH IS DRIVING MARKET GROWTH
FIGURE 12 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN SPATIAL GENOMICS AND TRANSCRIPTOMICS PRODUCTS MARKET IN 2019
FIGURE 13 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 14 TRANSLATIONAL RESEARCH APPLICATIONS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FROM 2020 TO 2025
FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY REGION,  2020 VS. 2025 (USD MILLION)
FIGURE 18 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 19 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SNAPSHOT
FIGURE 20 MARKET EVALUATION FRAMEWORK
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
FIGURE 22 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX, 2019
FIGURE 23 NANOSTRING TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
FIGURE 24 10X GENOMICS, INC.: COMPANY SNAPSHOT (2019)
FIGURE 25 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
FIGURE 26 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
FIGURE 27 BIO-TECHNE: COMPANY SNAPSHOT (2019)
FIGURE 28 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 29 GENOMIC VISION: COMPANY SNAPSHOT (2019)

This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global spatial genomics and transcriptomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, scientists & research scholars, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market growth prospects. The global size of the spatial genomics and transcriptomics market (estimated through various secondary research approaches) was then triangulated with inputs from primary research to arrive at the final market size.

Secondary DATA

The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, and Eurostat, among others.

Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global spatial genomics and transcriptomics market, which was validated through primary research. 

Primary DATA

Extensive primary research was conducted after acquiring basic knowledge about the global spatial genomics and transcriptomics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical & biotechnology companies and academic & research institutes as well as purchase managers in healthcare provider organizations) and the supply side (such as C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Approximately 50% and 50% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews..

Primary research was used in this report to:

  • Validate the market segmentation defined through product portfolio assessment of leading players in the spatial genomics & transcriptomics market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the spatial genomics & trancriptomics market and their market share/ranking

Breakdown of primary sources

Spatial Genomics & Transcriptomics Market Size

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the spatial genomics & transcriptomics market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the  spatial genomics & transcriptomics market

Report Objectives

  • To define, describe, segment, and forecast the spatial genomics & transcriptomics market on the basis of technique, product, application, end user, and region
  • To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall spatial genomics & transcriptomics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
  • To strategically profile the key players in the global spatial genomics & transcriptomics market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments, such as product launches, acquisitions, collaborations, expansions, and partnerships in the spatial genomics & transcriptomics market 

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the European spatial genomics & transcriptomics market into countries from the Rest of Europe segment.
  • Further breakdown of the Asia Pacific spatial genomics & transcriptomics market into countries from the Rest of the APAC segment.
  • Further breakdown of Latin America and the Middle East & Africa spatial genomics & transcriptomics market into countries.

Company Information

Detailed analysis and profiling of additional market players (up to 5) inclusive of:

  • Business Overview
  • Financial Information
  • Product Offered
  • Developments (Last three years)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Spatial Genomics & Transcriptomics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Spatial Genomics & Transcriptomics Market

Request For Special Pricing
Report Code
BT 7790
Published ON
Nov, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Spatial Genomics & Transcriptomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved